New Delhi, Aug. 27 -- Deepinder Goyal's health-tech venture Temple has acquired London-based Longevous, an evidence-based longevity medicine practice, as the company moves to strengthen its clinical and scientific capabilities ahead of the launch of its first wearable.

Goyal, who founded Temple after stepping away from the CEO role at Eternal, announced the acquisition in a LinkedIn post. The financial terms of the transaction have not been disclosed.

As part of the acquisition, Dr. Robert Mohr, co-founder of Longevous, will join Temple as Chief Medical Officer, while Dr. Avi Roy, the practice's other co-founder, will become Head of Science. Longevous will continue operating as before under Temple, with Mohr and Roy continuing to look a...